Healthcare
-
FDA to consider relaxing restrictions for peptides
The regulator said it is looking to take seven peptides off a restrictive list for unapproved drugs considered too risky.
-
Fake it ’til you make it: Study finds nearly half of health-related AI responses ‘problematic’
Researchers are concerned by the confident tone generative AI models use in their responses, considering their lack of credentials.
-
Shadow AI: What AI meeting note-takers mean for regulated industries
It’s the AI problem hiding in plain sight, says Manuela Bárcenas.
-
CHECKLIST: Is your AI meeting note-taker compliant?
A security checklist for regulated Industries.
-
Podiatrist, pharma rep sentenced to 63 months for healthcare fraud
In a case involving an unlicensed person performing medical procedures on unwitting patients, the two California men billed state and federal programs $3.2m in false claims.
-
FDA targets companies marketing unapproved weight‑loss drugs online
The FDA’s latest round of warning letters points to an intensifying regulatory trend targeting companies marketing and selling GLP-1 and related compounds online.
-
War with Iran hits global pharma and medical supply chain
The on-again, off-again closure of the Strait of Hormuz, the ongoing US war with Iran, and restrictions in air travel are having an impact on global pharmaceutical and medical supply chains.
-
IPPR defends UK healthcare funding model
Tax-funded systems have key advantages over their insurance-based counterparts, report finds.